Discover 878 paid clinical trials in Kentucky. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Kentucky presents diverse clinical research opportunities for healthy volunteers looking to get involved in paid studies, and those with specific health conditions alike. Major research centers in Louisville, Lexington, and Bowling Green are actively seeking participants, offering access to new treatments and advanced medical care.
Filter
1
Filter results
Results: 878
A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
for
Type 2 Diabetes
Location: Quebec, Brooklyn NY, Montreal, Morehead City NC,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT07754461
Phase 3, Recruiting
ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab
for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Brewer ME, Rockport ME, Brunswick ME, South Portland ME,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT06876714
Phase 3, Recruiting
Comparing Sentinel Lymph Node (SLN) Biopsy With Standard Neck Dissection for Patients With Early-Stage Oral Cavity Cancer
for
Buccal Mucosa Squamous Cell Carcinoma,
Location: New Haven CT, Lebanon NH, Commack NY, Trumbull CT,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT04333537
Phase 2, Phase 3, Recruiting
Comparing Acupuncture vs. Sham Acupuncture for the Management of Hot Flashes in Prostate Cancer Patients Receiving Hormone Therapy
for
Accupuncture, Prostate Cancer, Hormone Therapy, Hot Flashes
Location: Lexington KY
Sponsor: University of Kentucky
Sex: All
Age: 18 - 70+
Code: NCT07594002
Recruiting
The Impact of Cobenfy Maintenance on Cocaine's Effects
for
Cocaine Use Disorder (CUD)
Location: Lexington KY
Sponsor: Joshua A. Lile, Ph.D.
Sex: All
Age: 18 - 60
Code: NCT07624227
Phase 1, Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
for
Acute Myeloid Leukemia (AML)
Location: Worcester MA, Hartford CT, New Haven CT, New York NY,
Sponsor: Kura Oncology, Inc.
Sex: All
Age: 18+
Code: NCT07007312
Phase 3, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Hartford CT, Sherbrooke, New York NY, Montreal,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Location: New York NY, Washington D.C. DC, Richmond VA,
Sponsor: VA Office of Research and Development
Sex: All
Age: 60+
Code: NCT05996328
Recruiting
A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression
for
Ovarian Cancer
Location: Boston MA, Worcester MA, New York NY, Hackensack NJ,
Sponsor: Incyte Corporation
Sex: Female
Age: 18 - 70+
Code: NCT07023627
Phase 2, Recruiting
A Study Comparing Higher Dose Chemotherapy Over a Shorter Amount of Time to Lower Dose Chemotherapy Plus Maintenance Over a Longer Amount of Time in Patients With Newly Diagnosed Intermediate-Risk Rhabdomyosarcoma (IR RMS)
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as an Adjunct to Control Mild to Moderate Soft Tissue Bleeding During Surgery
for
Hemorrhage
Location: Washington D.C. DC, Charlotte NC, Columbus OH,
Sponsor: Corza Medical GmbH
Sex: All
Age: 0+
Code: NCT06664775
Phase 3, Recruiting
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis